thiamorpholine has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekka, EA; Theodosis-Nobelos, P; Tooulia, KK | 1 |
| Anderson, DG; Aresta-Dasilva, S; Bader, AR; Bochenek, MA; Chen, M; Doloff, JC; Gandham, S; Greiner, DL; Gürtler, M; Hollister-Lock, J; Jhunjhunwala, S; Langan, E; Langer, R; Li, J; McGarrigle, JJ; Melton, DA; Millman, JR; Oberholzer, J; Olejnik, K; Pagliuca, FW; Tam, HH; Vegas, AJ; Veiseh, O; Weir, GC | 1 |
| Barone, D; Chen, JM; Cummons, T; Du, M; Jin, G; Laakso, LM; Levin, JI; Schmid, J; Skotnicki, JS; Xu, J; Xu, W | 1 |
3 other study(ies) available for thiamorpholine and Disease Models, Animal
| Article | Year |
|---|---|
Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Biomarkers; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hyperlipidemias; Lipid Peroxidation; Lipoproteins, LDL; Molecular Structure; Morpholines; Polyethylene Glycols; Rats; Structure-Activity Relationship; Triglycerides | 2015 |
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.
Topics: Alginates; Animals; Blood Glucose; Blotting, Western; C-Peptide; Cell Culture Techniques; Cell Differentiation; Cell Transplantation; Chromatography, Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Embryonic Stem Cells; Flow Cytometry; Fluorescent Antibody Technique; Foreign-Body Reaction; Humans; Hydrogels; Immunocompetence; Insulin; Insulin-Secreting Cells; Mice; Microscopy, Confocal; Microscopy, Phase-Contrast; Morpholines; Polymers; Tandem Mass Spectrometry; Triazoles | 2016 |
Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.
Topics: Acetylene; ADAM Proteins; ADAM17 Protein; Administration, Oral; Alkynes; Animals; Arthritis; Caco-2 Cells; Collagen; Crystallography, X-Ray; Disease Models, Animal; Dogs; Enzyme Inhibitors; Haplorhini; Humans; Hydroxamic Acids; Lipopolysaccharides; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice; Molecular Structure; Morpholines; Propanols; Rats; Structure-Activity Relationship; Sulfonamides; Tumor Necrosis Factor-alpha | 2006 |